Modern Africa Today
SEE OTHER BRANDS

Your daily news update on Africa

Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on May 22, 2025

Globex Options Devils Pike (Golden Pike) New Brunswick Gold/Antimony property

Globex Options Devils Pike (Golden Pike) New Brunswick Gold/Antimony property

ROUYN-NORANDA, Quebec, May 22, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …

Globex signe une entente d’option sur sa propriété du Nouveau-Brunswick d’or/antimoine Devils Pike (Golden Pike)

Globex signe une entente d’option sur sa propriété du Nouveau-Brunswick d’or/antimoine Devils Pike (Golden Pike)

ROUYN-NORANDA, Québec, 22 mai 2025 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (GMX – Bourse de Toronto, G1MN – Bourses de Francfort, Stuttgart, Berlin, Munich, Tradegate, Lang …

DRILL PROGRAM BEGINS AT LAPON CANYON A NEVADA CANYON OWNED ROYALTY AND EXPORATION STREAM

DRILL PROGRAM BEGINS AT LAPON CANYON A NEVADA CANYON OWNED ROYALTY AND EXPORATION STREAM

Reno, Nevada, May 22, 2025 (GLOBE NEWSWIRE) -- Nevada Canyon Gold Corp. (OTCQX: NGLD) (The “Company” or “Nevada Canyon”) is pleased to announce it has been informed that the 2025 reverse circulation (“RC”) drill program has begun at the Lapon Canyon …

WALKER BEGINS DRILL PROGRAM AT LAPON CANYON

WALKER BEGINS DRILL PROGRAM AT LAPON CANYON

Vancouver, B.C, May 22, 2025 (GLOBE NEWSWIRE) -- Walker River Resources Corp. (“Walker” or the “Company”) (TSX-V: WRR) is pleased to announce that the 2025 reverse circulation (“RC”) drill program has begun at the Lapon Canyon portion of the Lapon Gold …

BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade

BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade

XI’AN, China, May 22, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive sales cooperation …

Is cloud mining really profitable? KixaMiner helps you realize your dream of wealth with cutting-edge solutions

Is cloud mining really profitable? KixaMiner helps you realize your dream of wealth with cutting-edge solutions

London, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- In today’s fast-changing cryptocurrency space, cloud mining has emerged as a popular way for many investors to earn passive income. However, with so many cloud mining platforms on the market, one …

Biodexa Announces Award of Additional $3.0M Grant from CPRIT to Support Registrational  eRapa Phase 3 Program in FAP  Brings Total CPRIT Grant Funding for eRapa Phase 3 Program to $20.0M

Biodexa Announces Award of Additional $3.0M Grant from CPRIT to Support Registrational eRapa Phase 3 Program in FAP Brings Total CPRIT Grant Funding for eRapa Phase 3 Program to $20.0M

May 22, 2025 Biodexa Announces Award of Additional $3.0M Grant from CPRIT to Support Registrational eRapa Phase 3 Program in FAP Brings Total CPRIT Grant Funding for eRapa Phase 3 Program to $20.0M Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ( …

Avalyn to Participate in the Jefferies Global Healthcare Conference in June

Avalyn to Participate in the Jefferies Global Healthcare Conference in June

CAMBRIDGE, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will participate in the …

GRI Bio Presents Positive Pre-Clinical Data Demonstrating GRI-0621 Resolves Inflammation and Fibrosis in Bleomycin-Induced Fibrosis and Reiterates Promising Preliminary Phase 2a Clinical Results

GRI Bio Presents Positive Pre-Clinical Data Demonstrating GRI-0621 Resolves Inflammation and Fibrosis in Bleomycin-Induced Fibrosis and Reiterates Promising Preliminary Phase 2a Clinical Results

Data presented at the 2025 American Thoracic Society (ATS) International Conference Pre-clinical and interim clinical results underscore GRI-0621’s potential to have both anti-inflammatory and anti-fibrotic effects in pulmonary fibrosis Results from 6-week …

BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release

BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …

Telix to Host Investor Day in New York City on June 11, 2025

Telix to Host Investor Day in New York City on June 11, 2025

MELBOURNE, Australia and INDIANAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces it will host an Investor Day on Wednesday, June 11, 2025, in person, in New York City, …

Plato Gold Reports on First Quarter Results

Plato Gold Reports on First Quarter Results

Toronto, ON, May 22, 2025 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) an exploration company with a portfolio of properties in Northern Ontario and Santa Cruz, Argentina is …

InflaRx to Participate in Upcoming Investor Conferences

InflaRx to Participate in Upcoming Investor Conferences

JENA, Germany, May 22, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will participate in multiple investor …

Quoin Pharmaceuticals Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study

Quoin Pharmaceuticals Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study

Study CL-QRX003-002 will test whole-body application of QRX003 in conjunction with off-label systemic therapy in approximately 12-15 subjects. Study CL-QRX003-002 complements first whole-body pivotal study, CL-QRX003-003, being led by Dr. Amy Paller at …

NexGold Receives Cabinet Approval for the Crown Land Lease at the Goldboro Gold Project

NexGold Receives Cabinet Approval for the Crown Land Lease at the Goldboro Gold Project

TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce that the Crown Land Lease and License for the Goldboro Gold Project (“Goldboro” or the “Project”) has been …

Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences

Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences

CAMBRIDGE, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced …

Trident Resources Announces Appointment of Canadian Mining Hall of Famer Ron Netolitzky as a Strategic Advisor

Trident Resources Announces Appointment of Canadian Mining Hall of Famer Ron Netolitzky as a Strategic Advisor

Vancouver, BC, May 22, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce the appointment of renowned geologist and executive Mr. Ronald Netolitzky to help guide and advise the …

Replimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Replimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

•  BLA priority review of RP1 plus nivolumab in advanced melanoma proceeding on schedule; manufacturing inspections and late cycle review meeting complete •  Full commercial infrastructure for launch in place ahead of July 22nd PDUFA date •  Conference …

Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA

Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA

 Presentations by leading siRNA CDMOs, Bachem, Nitto Avecia, and ST Pharm, highlight performance and transferability of Codexis double-stranded RNA ligases Management to host conference call today at 8 am Eastern Time to discuss data REDWOOD CITY, Calif., …

Azimut fore 1,1% Sb sur 51,5 m, incluant 3,43% Sb et 2,37 g/t Au sur 6,5 m

Azimut fore 1,1% Sb sur 51,5 m, incluant 3,43% Sb et 2,37 g/t Au sur 6,5 m

LONGUEUIL, Québec, 22 mai 2025 (GLOBE NEWSWIRE) -- Exploration Azimut Inc. (« Azimut » ou la « Société ») (TSXV : AZM) (OTCQX : AZMTF) a le plaisir de présenter des résultats très encourageants à la suite de son programme de forage au diamant réalisé pour …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service